Cyclo Therapeutics, Inc. is a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease. The company's drug candidate, Trappsol® Cyclo™, an orphan drug designated product in the United States and Europe, is currently in a Phase 3 study for the treatment of Niemann-Pick Disease Type C, a rare and fatal genetic disease. More information can be found at clinicaltrials.gov under study ID NCT04860960. Additional indications for the active ingredient in Trappsol® Cyclo™, are in development such as Alzheimer's disease, NCT05607615.
One can search on Google Maps directly for Cyclo Therapeutics. We are located just five minutes from the NW Gainesville Walmart at 5700 NW 23rd.
